RNAi: antiviral therapy against dengue virus.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMC 3631757)

Published in Asian Pac J Trop Biomed on March 01, 2013

Authors

Sobia Idrees1, Usman A Ashfaq

Author Affiliations

1: Department of Bioinformatics and Biotechnology, Government College University (GCU), Faisalabad, Pakistan.

Articles cited by this

Dengue. Lancet (2007) 10.54

Dengue: a continuing global threat. Nat Rev Microbiol (2010) 9.96

Dengue: an update. Lancet Infect Dis (2002) 9.02

RNA-triggered gene silencing. Trends Genet (1999) 5.36

Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci U S A (2003) 5.05

The role of RNA interference in heterochromatic silencing. Nature (2004) 4.56

Engineering RNA interference-based resistance to dengue virus type 2 in genetically modified Aedes aegypti. Proc Natl Acad Sci U S A (2006) 3.62

Evolutionary relationships of endemic/epidemic and sylvatic dengue viruses. J Virol (2000) 3.21

Dengue virus type 2 infections of Aedes aegypti are modulated by the mosquito's RNA interference pathway. PLoS Pathog (2009) 3.09

Best practices in dengue surveillance: a report from the Asia-Pacific and Americas Dengue Prevention Boards. PLoS Negl Trop Dis (2010) 2.45

RNA interference: biology, mechanism, and applications. Microbiol Mol Biol Rev (2003) 2.19

RNA interference against viruses: strike and counterstrike. Nat Biotechnol (2007) 2.14

RNA interference, arthropod-borne viruses, and mosquitoes. Virus Res (2004) 2.06

Architecture of the flaviviral replication complex. Protease, nuclease, and detergents reveal encasement within double-layered membrane compartments. J Biol Chem (2003) 1.92

Inhibition of virus replication by RNA interference. J Biomed Sci (2003) 1.70

RIG-I, MDA5 and TLR3 synergistically play an important role in restriction of dengue virus infection. PLoS Negl Trop Dis (2011) 1.50

Dengue virus serotype infection specifies the activation of the unfolded protein response. Virol J (2007) 1.41

The silent treatment: RNAi as a defense against virus infection in mammals. Trends Biotechnol (2006) 1.27

Molecular dissection of the gibberellin/abscisic acid signaling pathways by transiently expressed RNA interference in barley aleurone cells. Plant Cell (2002) 1.19

Serotype and genotype analysis of dengue virus by sequencing followed by phylogenetic analysis using samples from three mini outbreaks-2007-2009 in Pakistan. BMC Microbiol (2011) 1.11

Dengue virus. Clin Lab Med (2010) 1.07

RNAi: gene-silencing in therapeutic intervention. Drug Discov Today (2002) 1.07

Small interference RNA profiling reveals the essential role of human membrane trafficking genes in mediating the infectious entry of dengue virus. Virol J (2010) 1.05

RNAi in the regulation of mammalian viral infections. BMC Biol (2012) 1.04

RNA interference: its use as antiviral therapy. Handb Exp Pharmacol (2006) 0.99

Inhibition of dengue virus infections in cell cultures and in AG129 mice by a small interfering RNA targeting a highly conserved sequence. J Virol (2011) 0.98

RNA interference modulates replication of dengue virus in Drosophila melanogaster cells. BMC Microbiol (2010) 0.97

Adenovirus delivered short hairpin RNA targeting a conserved site in the 5' non-translated region inhibits all four serotypes of dengue viruses. PLoS Negl Trop Dis (2012) 0.95

RNA interference: antiviral weapon and beyond. World J Gastroenterol (2003) 0.95

RNA interference mediated silencing of Hsp60 gene in human monocytic myeloma cell line U937 revealed decreased dengue virus multiplication. Immunobiology (2009) 0.93

Attenuation of dengue virus infection by adeno-associated virus-mediated siRNA delivery. Genet Vaccines Ther (2004) 0.89

RNA interference: the story of gene silencing in plants and humans. Biotechnol Adv (2007) 0.89

Inhibitory effect of small interfering RNA on dengue virus replication in mosquito cells. Virol J (2010) 0.89

siRNAs: potential therapeutic agents against hepatitis C virus. Virol J (2011) 0.87

RNA interference and its role in the regulation of eucaryotic gene expression. Acta Biochim Pol (2003) 0.86

RNA interference mediated inhibition of dengue virus multiplication and entry in HepG2 cells. PLoS One (2012) 0.84

[Study on the inhibitory effect of RNA interference on replication of dengue virus]. Bing Du Xue Bao (2010) 0.80

Bioinformatics prediction of siRNAs as potential antiviral agents against dengue viruses. Bioinformation (2012) 0.79

Articles by these authors

A brief review on dengue molecular virology, diagnosis, treatment and prevalence in Pakistan. Genet Vaccines Ther (2012) 1.21

Dual behavior of HCV Core gene in regulation of apoptosis is important in progression of HCC. Infect Genet Evol (2012) 0.92

NS4A protein as a marker of HCV history suggests that different HCV genotypes originally evolved from genotype 1b. Virol J (2011) 0.89

Antiviral activity of Acacia nilotica against Hepatitis C Virus in liver infected cells. Virol J (2011) 0.88

The epidemic of HIV/AIDS in developing countries; the current scenario in Pakistan. Virol J (2011) 0.83

Hepatitis C virus to hepatocellular carcinoma. Infect Agent Cancer (2012) 0.82

Development of global consensus sequence of HCV glycoproteins involved in viral entry. Theor Biol Med Model (2013) 0.79

HCV Envelope protein 2 sequence comparison of Pakistani isolate and In-silico prediction of conserved epitopes for vaccine development. J Transl Med (2013) 0.78

Structural analysis and epitope prediction of HCV E1 protein isolated in Pakistan: an in-silico approach. Virol J (2013) 0.78

Anti-apoptotic effect of HCV core gene of genotype 3a in Huh-7 cell line. Virol J (2011) 0.77

Molecular screening of phytochemicals from Amelanchier Alnifolia against HCV NS3 protease/helicase using computational docking techniques. Bioinformation (2013) 0.76

Global consensus sequence development and analysis of dengue NS3 conserved domains. Biores Open Access (2013) 0.75

Screening of medicinal plant phytochemicals as natural antagonists of p53-MDM2 interaction to reactivate p53 functioning. Anticancer Drugs (2017) 0.75